Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Schedule of Long-lived Assets by Geographic Area

Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December 31, 2021, 2020 and 2019, consisted of the following (in thousands):

	2021		2020		2019
United States	$	275,311	$	277,643	$	273,816
Ireland		39,863		42,951		44,912
Other foreign countries		56,484		62,134		60,057
Total	$	371,658	$	382,728	$	378,785

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2021, 2020 and 2019, are as follows (in thousands):

	2021		2020		2019
Net Sales
Cardiovascular	$	1,043,227	$	934,202	$	960,981
Endoscopy		31,524		29,673		33,871
Total net sales		1,074,751		963,875		994,852
Operating Income (Loss)
Cardiovascular		53,415		(7,042)		25,780
Endoscopy		7,501		5,480		(10,346)
Total operating income (loss)		60,916		(1,562)		15,434
Total other expense - net		(6,999)		(11,669)		(13,241)
Income tax expense (benefit)		5,463		(3,388)		(3,258)
Net income (loss)	$	48,454	$	(9,843)	$	5,451

Total depreciation and amortization by operating segment for the years ended December 31, 2021, 2020 and 2019, consisted of the following (in thousands):

	2021		2020		2019
Cardiovascular	$	83,000	$	93,160	$	91,151
Endoscopy		1,066		910		949
Total	$	84,066	$	94,070	$	92,100

Total capital expenditures for property and equipment by operating segment for the years ended December 31, 2021, 2020 and 2019, consisted of the following (in thousands):

	2021		2020		2019
Cardiovascular	$	27,557	$	45,803	$	77,631
Endoscopy		382		185		542
Total	$	27,939	$	45,988	$	78,173

Reconciliation of Assets from Segment to Consolidated

	2021		2020		2019
Net Sales
Cardiovascular	$	1,043,227	$	934,202	$	960,981
Endoscopy		31,524		29,673		33,871
Total net sales		1,074,751		963,875		994,852
Operating Income (Loss)
Cardiovascular		53,415		(7,042)		25,780
Endoscopy		7,501		5,480		(10,346)
Total operating income (loss)		60,916		(1,562)		15,434
Total other expense - net		(6,999)		(11,669)		(13,241)
Income tax expense (benefit)		5,463		(3,388)		(3,258)
Net income (loss)	$	48,454	$	(9,843)	$	5,451